GI toxicity

Giorgos Bamias (Athens, Greece)

Source: ERS Skills course: Multi-disciplinary care in thoracic oncology

Number: 7

Disease area: -

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Giorgos Bamias (Athens, Greece). GI toxicity. ERS Skills course: Multi-disciplinary care in thoracic oncology

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Respiratory failure from an upper gastrointestinal series Source: Eur Respir Rev 2014; 23: 396-397 Year: 2014
Efficacy and safety of Cefdinir in lower respiratory tract infections Source: Eur Respir J 2002; 20: Suppl. 38, 420s Year: 2002
Pharmacological interactions between antibiotics and other drugs in the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=229 Year: 2004
Lower respiratory tract infections in haematologic patients with and without stemcell transplantation Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012
Pharmacogenomics and drug-induced toxicity Source: Annual Congress 2009 - PG7 Drug-induced pulmonary toxicity Year: 2009
Inhibition of upper respiratory tract inflammation leads to inhibition of lower respiratory tract inflammation Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010
Initial hyperglycaemia as predictor of severity for children‘s lower respiratory tract infection Source: Eur Respir J 2005; 26: Suppl. 49, 168s Year: 2005
Sinecology of respiratory tract microflora Source: Annual Congress 2006 - Miscellaneous respiratory infections II Year: 2006
Immunomodulatory effects of moxifloxacin in human respiratory tract infection Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010
The safety of LAMA/LABA combination therapy for the ocular and urinary adverse effects in the COPD patients Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019
Dermatologic toxicity Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019
Impact of bacterial colonization in lower respiratory tract on fibrile episode in patietns with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 1s Year: 2003
Chlorine exposure and the upper respiratory tract Source: Eur Respir J 2002; 19: 381-383 Year: 2002
Fatal outcome in lower respiratory tract infections Source: Eur Respir J 2004; 24: Suppl. 48, 186s Year: 2004
Some aspects of mucosal immune response in children with bacterial upper respiratory tract infections Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans Year: 2019
Linking pathophysiology of lower respiratory tract infections with clinical expression Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection Year: 2007
Pancreatic, gastrointestinal and liver disease Source: ERS course 2015 Year: 2015
Nasal microbiota and symptom persistence in acute respiratory tract infections in infants Source: ERJ Open Res, 4 (4) 00066-2018; 10.1183/23120541.00066-2018 Year: 2018
The lung microbiome and its effects on respiratory infections Source: Virtual Congress 2020 – Respiratory infections Year: 2020
Evaluation of antibiotics therapy for low respiratory tract infections Source: Eur Respir J 2007; 30: Suppl. 51, 406s Year: 2007